Find, compare & contact
L-Glutamic Acid API Manufacturers & Suppliers

Looking for L-Glutamic Acid API 56-86-0?

Description:

Here you will find a list of producers, manufacturers and distributors of L-Glutamic Acid. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

L-Glutamic Acid 

Synonyms:

Glu , Glutamic acid , L-Glutamate , L-Glutaminic acid  

Cas Number:

56-86-0 

DrugBank number:

DB00142 

Unique Ingredient Identifier:

3KX376GY7L

L-Glutamic Acid is a type of Central Nervous System Agents

Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.

CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.

The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.

Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.

• Wuxi Jinghai Amino Acid Co., Ltd from China, product country of origin China
• Senova Technology Co., Ltd. from China, product country of origin China
• Taenaka Kogyo from Japan, product country of origin Japan
• Evonik Rexim from China, product country of origin Unknown
• Wuhan Amino Acid Bio-Chemical Co Ltd from China, product country of origin China
• Sekisui Medical from Japan, product country of origin Japan
• Medinex Labs. from India, product country of origin India
• Ajinomoto from Japan, product country of origin Unknown
• Zhejiang Tianrui Chemical Co.,Ltd. from China, product country of origin China
• Amino GmbH from Germany, product country of origin Germany

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.